SamSearch
    Wall of LovePricing
    Book a DemoSign In
    LogoSamSearch
    Close contracts faster than humanly possible.
    Ask AI About SamSearch

    Ask your favorite AI assistant about SamSearch and government contracting.

    • Ask ChatGPT
    • Ask Claude
    • Ask Perplexity
    YoutubeLinkedinDiscordTwitterMedium Facebook
    Contact Us
    Terms of Use
    Privacy Policy
    Trust Center
    Support
    Pricing
    ROI Calculator
    Careers
      Resources
      • Guides
      • Implementation Plan
      • Free GovCon Tools
      • NAICS AI Search
      • Capability Statement Builder
      • GovCon Glossary
      • Contracts
      • Set-Aside Programs
      • Statistics
      • Blog
      • Changelog
      • Comparisons
      • Alternatives
      • Docs
      • Browse NAICS Codes
      Home/News/Topics/Medical Marijuana

      Topics

      Medical Marijuana

      1 signal

      Signals

      Regulatory ComplianceHealthcareMedical MarijuanaProcurement OpportunitiesPolicy
      3 days ago

      DOJ Reschedules Marijuana Products: Implications for Medical Research and Procurement

      The DOJ and DEA have reclassified FDA-approved marijuana products to Schedule III, enhancing research opportunities. This change promises clearer guidelines for healthcare and research providers involved in marijuana-based treatments, leading to potential federal contracting opportunities.